smn2 splicing modifiers improve motor function longevity mice spinal muscular atrophy
spinal muscular atrophy sma genetic disease caused mutation deletion survival motor neuron smn1 gene paralogous gene humans smn2 produces low insufficient levels functional smn protein due alternative splicing truncates transcript decreased levels smn protein lead progressive neuromuscular degeneration high rates mortality chemical screening optimization identified orally available small molecules shift balance smn2 splicing toward production full-length smn2 messenger rna high selectivity administration compounds d7 mice model severe sma led increase smn protein levels improvement motor function protection neuromuscular circuit compounds also extended life span mice selective smn2 splicing modifiers may therapeutic potential patients sma
